Unlock The Future Of Market Access In 2026: Cencora's Essential Guide To Navigating A Shifting Healthcare Landscape

Cencora’s FY26 Market Access Trends Report analyzes the shifting global landscape as the industry approaches 2026, a year expected to bring increased focus on proactive strategies and technological advances. To navigate major policy shifts—such as the EU Joint Clinical Assessment—and evolving payer expectations, manufacturers must balance early strategic planning with organizational agility. Biopharma companies are increasingly prioritizing the integration of regulatory and payer strategies earlier in the product lifecycle to address resource barriers and new legislation. Beyond policy, the application of artificial intelligence in economic modeling and real-world evidence generation offers critical opportunities to streamline workflows and address data gaps.

From the rapid growth of anti-obesity medications to the demand for fit-for-purpose data, understanding these dynamics is essential for commercial success. Download the full report to prepare for the complexities of the 2026 market access environment.